(Q74505903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Lack of mda-6/WAF1/CIP1-mediated inhibition of cyclin-dependent kinases in interferon-alpha resistant murine B16 melanoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

I Arany

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C M Fleischmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S K Tyring

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

W R Fleischmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

237-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

Development and mechanisms of interferon resistance

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Interferon regulates expression of mda-6/WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 murine melanoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900288-7

7 January 2021

10.1016/S0304-3835(97)00288-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9570377%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference